Stock News
Uncovering the Success Story of Viking Therapeutics Inc. (VKTX): Key Facts and Market Performance
The Impact of Viking Therapeutics, Inc. Stock on the Market Understanding the Recent Trading Day In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $64.96, denoting a +1.33% change from the preceding trading day. This fluctuation in stock price has caught the attention of investors and analysts alike, sparking discussions…
Don’t Miss Out: Protect Your Investment in PDD Holdings Inc. (formerly Pinduoduo Inc.) – Important Deadline Approaching for Securities Class Action
The Importance of Protecting Investor Rights Introduction Investing in the stock market can be a risky endeavor, and investors are often vulnerable to securities fraud and misconduct. It is crucial for investor rights to be protected in order to maintain fairness and integrity in the financial markets. Rosen Law Firm Reminder Recently, Rosen Law Firm…
Calling All Paragon 28 Inc. Investors: Don’t Miss Out on Important Deadline for Securities Class Action – Get Counsel with ROSEN Leading Investor Counsel!
Welcome to the Class Action Lawsuit Party! What’s the Deal with Paragon 28’s Stock? So, it seems like Rosen Law Firm is stirring up some drama with a class action lawsuit against Paragon 28, Inc. for all those folks who bought their common stock between May 5, 2023 and August 8, 2024. And let’s not…
Unlocking Potential: Pasofino Gold’s Exciting Non-Brokered Private Placement Opportunity of up to US$2.5 Million
The Impact of Pasofino Gold Limited’s Private Placement Offering Introduction On October 4, 2024, Pasofino Gold Limited announced a non-brokered private placement offering, which has significant implications for the company and its investors. The offering consists of up to 4,806,767 units at a price of C$0.70 per unit, with gross proceeds of up to C$3,364,737….
Innovative and Articulate: Deveron Announces Successful Debt Settlement
Deveron Corp. Announces Settlement of Promissory Note October 4, 2024 Toronto, Ontario–(Newsfile Corp. – October 4, 2024) – Deveron Corp. (TSXV: FARM) (“Deveron” or the “Company”), a leading agriculture services and data company in North America, is pleased to announce that further to its press releases of August 15, 2024 and September 16, 2024, the…
Breaking News: Spyre Therapeutics Awards Inducement Grants – A Major Step Forward in Advancing Medical Innovation
Spyre Therapeutics Announces Equity Inducement Awards WALTHAM, Mass. , Oct. 4, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently made an exciting announcement regarding equity inducement awards. The company is focused on utilizing innovative antibody engineering, therapeutic combinations, and precision medicine to enhance the treatment of Inflammatory Bowel Disease…
OnKure Announces Successful Merger with Reneo Pharmaceuticals and $65 Million Private Placement
OnKure Therapeutics Announces Merger Completion and Milestones Achieved Advancing Precision Medicines in Oncology OnKure Therapeutics, a clinical-stage biopharmaceutical company based in Boulder, Colorado, is dedicated to advancing a pipeline of candidates targeting oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα), with an initial focus on breast cancer. The company recently announced the completion of its merger…
Cidara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cidara Therapeutics, Inc. Grants Stock Options and RSUs to New Employee New Employee Receives Stock Options and RSUs Cidara Therapeutics, Inc., a biotechnology company focused on developing drug-Fc conjugate immunotherapies, recently announced that the Compensation Committee of its Board of Directors has granted Dipesh Bhatt, a new employee, a non-qualified stock option award and restricted…